Crossmark

T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10

Crossref DOI link: https://doi.org/10.1038/s41467-022-28523-1

Published Online: 2022-02-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ravi, Vidhya M. https://orcid.org/0000-0003-0062-2099
Neidert, Nicolas https://orcid.org/0000-0003-0299-1138
Will, Paulina https://orcid.org/0000-0001-5924-2432
Joseph, Kevin https://orcid.org/0000-0001-6317-8736
Maier, Julian P. https://orcid.org/0000-0002-2957-9031
Kückelhaus, Jan

Vollmer, Lea

Goeldner, Jonathan M. https://orcid.org/0000-0003-2394-7312
Behringer, Simon P.

Scherer, Florian https://orcid.org/0000-0001-9635-5487
Boerries, Melanie

Follo, Marie

Weiss, Tobias https://orcid.org/0000-0002-5533-9429
Delev, Daniel

Kernbach, Julius https://orcid.org/0000-0002-0256-1923
Franco, Pamela

Schallner, Nils

Dierks, Christine

Carro, Maria Stella https://orcid.org/0000-0002-8570-7691
Hofmann, Ulrich G.

Fung, Christian

Sankowski, Roman https://orcid.org/0000-0001-9215-8021
Prinz, Marco https://orcid.org/0000-0002-0349-1955
Beck, Jürgen

Salié, Henrike https://orcid.org/0000-0002-2993-3782
Bengsch, Bertram https://orcid.org/0000-0003-2552-740X
Schnell, Oliver

Heiland, Dieter Henrik https://orcid.org/0000-0002-9258-3033
Funding

Funding for this research was provided by:

Bundesministerium für Bildung und Forschung
License Information

Text and Data Mining valid from 2022-02-17

Version of Record valid from 2022-02-17
More Information

Article History

Received: 26 February 2021

Accepted: 26 January 2022

First Online: 17 February 2022

Competing interests

: D.H.H. received reimbursement of travel expenses from 10X and the MILO laboratory is part of the 10X VEP program. The authors declare no competing interests.

Document is current

Any future updates will be listed below